Cubist Systematic Strategies, LLC Cue Biopharma, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.1 Billion
- Q4 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 3,661 shares of CUE stock, worth $2,782. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,661Holding current value
$2,782% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding CUE
# of Institutions
56Shares Held
11.5MCall Options Held
22KPut Options Held
1.2K-
Bleichroeder LP New York, NY5MShares$3.8 Million1.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$1.56 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$575,1190.0% of portfolio
-
Geode Capital Management, LLC Boston, MA631KShares$479,7730.0% of portfolio
-
Robertson Stephens Wealth Management, LLC San Francisco, CA479KShares$363,6600.02% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $26.9M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...